120 related articles for article (PubMed ID: 27381867)
1. Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: Possible involvement of ROS and thioredoxin reductase.
Jayakumar S; Patwardhan RS; Pal D; Sharma D; Sandur SK
Biochem Biophys Res Commun; 2016 Sep; 478(1):446-454. PubMed ID: 27381867
[TBL] [Abstract][Full Text] [Related]
2. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes.
Patwardhan RS; Checker R; Sharma D; Kohli V; Priyadarsini KI; Sandur SK
Biochem Pharmacol; 2011 Sep; 82(6):642-57. PubMed ID: 21726543
[TBL] [Abstract][Full Text] [Related]
3. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells.
Simon E; Aswini P; Sameer Kumar VB; Mankadath G
Free Radic Res; 2018 May; 52(5):583-591. PubMed ID: 29621898
[TBL] [Abstract][Full Text] [Related]
5. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
Liang YW; Zheng J; Li X; Zheng W; Chen T
Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
[TBL] [Abstract][Full Text] [Related]
6. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage.
Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X
Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096
[TBL] [Abstract][Full Text] [Related]
7. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
[TBL] [Abstract][Full Text] [Related]
8. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
9. Differential antioxidant/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of curcumin.
Kunwar A; Barik A; Sandur SK; Indira Priyadarsini K
Free Radic Res; 2011 Aug; 45(8):959-65. PubMed ID: 21615275
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a curcumin analogue dimethoxycurcumin with DNA.
Kunwar A; Simon E; Singh U; Chittela RK; Sharma D; Sandur SK; Priyadarsini IK
Chem Biol Drug Des; 2011 Apr; 77(4):281-7. PubMed ID: 21244640
[TBL] [Abstract][Full Text] [Related]
11. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
[TBL] [Abstract][Full Text] [Related]
12. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
[TBL] [Abstract][Full Text] [Related]
13. Injectable (-)-gossypol-loaded Pluronic P85 micelles for cancer chemoradiotherapy.
Tomoda K; Chiang HC; Kozak KR; Kwon GS
Int J Radiat Biol; 2017 Apr; 93(4):402-406. PubMed ID: 27827005
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells.
Hirai T; Saito S; Fujimori H; Matsushita K; Nishio T; Okayasu R; Masutani M
Biochem Biophys Res Commun; 2016 Sep; 478(1):234-240. PubMed ID: 27425251
[TBL] [Abstract][Full Text] [Related]
15. TAT-RasGAP
Tsoutsou P; Annibaldi A; Viertl D; Ollivier J; Buchegger F; Vozenin MC; Bourhis J; Widmann C; Matzinger O
Radiat Res; 2017 May; 187(5):562-569. PubMed ID: 28323576
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin.
Tamvakopoulos C; Dimas K; Sofianos ZD; Hatziantoniou S; Han Z; Liu ZL; Wyche JH; Pantazis P
Clin Cancer Res; 2007 Feb; 13(4):1269-77. PubMed ID: 17317839
[TBL] [Abstract][Full Text] [Related]
17. Dimethoxycurcumin reduces proliferation and induces apoptosis in renal tumor cells more efficiently than demethoxycurcumin and curcumin.
Zanetti TA; Biazi BI; Coatti GC; Baranoski A; Marques LA; Corveloni AC; Mantovani MS
Chem Biol Interact; 2021 Apr; 338():109410. PubMed ID: 33582110
[TBL] [Abstract][Full Text] [Related]
18. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
Shehzad A; Park JW; Lee J; Lee YS
Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
[TBL] [Abstract][Full Text] [Related]
19. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
20. Mitotic spindle defects and DNA damage induced by dimethoxycurcumin lead to an intrinsic apoptosis pathway in HepG2/C3A cells.
Zanetti TA; Biazi BI; Coatti GC; Baranoski A; Marques LA; Corveloni AC; Mantovani MS
Toxicol In Vitro; 2019 Dec; 61():104643. PubMed ID: 31513842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
